Other Events ·
Lexaria Bioscience Corp. received confirmation from Nasdaq that it has regained compliance with the minimum bid price…
LEXXWLexaria Bioscience Corp.
Lexaria Bioscience Corp. received confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2). As a result of this cure, the previously requested hearing regarding the deficiency was cancelled, and the company's Common Stock will continue to be listed on The Nasdaq Capital Market. Lexaria Bioscience Corp. operates in the biotechnology industry, focusing on the development of cannabis-based therapeutics.